Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike A Wieland

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Handbook of Experimental Pharmacology|August 27, 2024
Novel and Proven Models of Public, Private, and Public-Private Partnerships in Healthcare: An UpdateHeike A Wieland, Jochen Maas
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
Approaches in anticoagulation: rationales for target positioningHeike A Wieland, Volker Laux, Detlef Kozian, et al.
Nature Reviews. Drug Discovery|April 2, 2005
Osteoarthritis - an untreatable disease?Heike A Wieland, Martin Michaelis, Bernhard J Kirschbaum, et al.
Biochemistry|June 19, 2002
Ala31-Aib32: identification of the key motif for high affinity and selectivity of neuropeptide Y at the Y5-receptorChiara Cabrele, Heike A Wieland, Norman Koglin, et al.
Regulatory Peptides|March 1, 2003
Characterization of the NPGP receptor and identification of a novel short mRNA isoform in human hypothalamusBaerbel Laemmle, Marcus Schindler, Mario Beilmann, et al.
European Journal of Biochemistry|February 22, 2002
The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptorHeike A Wieland, Richard M Söll, Henri N Doods, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 9, 2005
Validation of a diffusion chamber as in vitro system for the analysis of compound diffusibility through cartilage tissueAlexander Kreiselmeier, Wolfgang Ulmer, Johannes Stöve, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Handbook of Experimental Pharmacology|August 27, 2024
Novel and Proven Models of Public, Private, and Public-Private Partnerships in Healthcare: An UpdateHeike A Wieland, Jochen Maas
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
Approaches in anticoagulation: rationales for target positioningHeike A Wieland, Volker Laux, Detlef Kozian, et al.
Nature Reviews. Drug Discovery|April 2, 2005
Osteoarthritis - an untreatable disease?Heike A Wieland, Martin Michaelis, Bernhard J Kirschbaum, et al.
Biochemistry|June 19, 2002
Ala31-Aib32: identification of the key motif for high affinity and selectivity of neuropeptide Y at the Y5-receptorChiara Cabrele, Heike A Wieland, Norman Koglin, et al.
Regulatory Peptides|March 1, 2003
Characterization of the NPGP receptor and identification of a novel short mRNA isoform in human hypothalamusBaerbel Laemmle, Marcus Schindler, Mario Beilmann, et al.
European Journal of Biochemistry|February 22, 2002
The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptorHeike A Wieland, Richard M Söll, Henri N Doods, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 9, 2005
Validation of a diffusion chamber as in vitro system for the analysis of compound diffusibility through cartilage tissueAlexander Kreiselmeier, Wolfgang Ulmer, Johannes Stöve, et al.
Pageof 1